Clinical Trial Update: Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated fondaparinux in combination with unfractionated heparin during revascularization in acute coronary syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Fondaparinux (fondaparinux)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2011-06-07